Clinical effectiveness of defibrotide in vaso-occlusive disorders and its mode of actions

Semin Thromb Hemost. 1988:14 Suppl:58-63.

Author

O N Ulutin¹

Affiliation

¹ Department of Medicine, Cerrahpasa Medical School, Istanbul University, Turkey.

PMID: 2848323

No abstract available

MeSH terms

6-Ketoprostaglandin F1 alpha / blood
Angiography
Arteriosclerosis / drug therapy*
Cyclic AMP / blood
Female
Fibrinolytic Agents / pharmacology
Fibrinolytic Agents / therapeutic use*
Humans
Male
Middle Aged
Physical Exertion
Polydeoxyribonucleotides / pharmacology
Polydeoxyribonucleotides / therapeutic use*
Thromboangiitis Obliterans / drug therapy*
Thromboxane B2 / blood

Substances

Fibrinolytic Agents
Polydeoxyribonucleotides
defibrotide
Thromboxane B2
6-Ketoprostaglandin F1 alpha
Cyclic AMP